Company Update: Merck & Co. Inc. (NYSE:MRK) – Merck Sues Actavis Unit Over Patent for Generic NuvaRing

December 24, 2013 at 11:01 AM EST

[at Bloomberg] – Merck & Co. sued Actavis Plc’s Warner Chilcott unit seeking to block a generic version of NuvaRing, a contraceptive with annual sales in the hundreds of millions of dollars. Read . . . → Read More: Company Update: Merck & Co. Inc. (NYSE:MRK) – Merck Sues Actavis Unit Over Patent for Generic NuvaRing Similar posts: American International Group (NYSE:AIG) | AIG selling aircraft leasing unit in $5.4B deal Company Update: Johnson & Johnson (NYSE:JNJ) – EU regulators fine J&J, Novartis for generic drug deal Google Inc. (NASDAQ:GOOG) ~ HTC One KitKat update coming to Google Play edition smartphones

Merck & Co. Inc. (NYSE:MRK) [at Bloomberg] – Merck & Co. sued Actavis Plc’s Warner Chilcott unit seeking to block a generic version of NuvaRing, a contraceptive with annual sales in the hundreds of millions of dollars.
Read more on this.

… [visit site to read more]